Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Cash from Investing Activities (2016)

Microbot Medical's Cash from Investing Activities history spans 7 years, with the latest figure at -$1.5 million for Q4 2016.

  • For the quarter ending Q4 2016, Cash from Investing Activities fell 277.15% year-over-year to -$1.5 million, compared with a TTM value of -$25000.0 through Dec 2016, down 1150.0%, and an annual FY2025 reading of -$72.4 million, down 4809.43% over the prior year.
  • Cash from Investing Activities for Q4 2016 was -$1.5 million at Microbot Medical, down from $1.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $6.3 million in Q2 2013, with the low at -$7.9 million in Q4 2012.
  • Average Cash from Investing Activities over 5 years is -$105427.4, with a median of -$102626.5 recorded in 2014.
  • Year-over-year, Cash from Investing Activities plummeted 505.11% in 2012 and then soared 1347.68% in 2013.
  • Tracing MBOT's Cash from Investing Activities over 5 years: stood at -$7.9 million in 2012, then skyrocketed by 96.87% to -$248221.0 in 2013, then soared by 169.62% to $172810.0 in 2014, then skyrocketed by 382.94% to $834560.0 in 2015, then tumbled by 277.15% to -$1.5 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Cash from Investing Activities are -$1.5 million (Q4 2016), $1.5 million (Q3 2016), and -$9500.0 (Q2 2016).